Trial intelligence / Profile preview

Effects of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects

NCT07426042Phase 1Not yet recruiting

Start
Apr 2026
Primary completion
May 2026
Modality
Orthosteric Ligands
01

Overview

Phase 1, open-label, single-arm trial of dexamethasone. Primary endpoints: Maximum Plasma Concentration of CYP Probe Substrates, Area Under the Concentration-Time Curve from Time Zero to the Last Quantifiable Concentration of CYP Probe Substrates and 1 more. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

dexamethasone

Beyond the preview

Go deeper on NCT07426042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07426042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call